|
CN104744374A
|
|
A preparing method of bendamustine hydrochloride
|
|
CN103923154A
|
|
Eutectic of ulipristal acetate and preparation method thereof
|
|
CN103845294A
|
|
Injectable temozolomide powder injection preparation and preparation method thereof
|
|
CN102850418A
|
|
Crystallizing and drying method for preparing high-purity azacitidine
|
|
CN102643214A
|
|
Preparation method and preparation of vorinostat I crystal form large grains
|
|
CN102614139A
|
|
Solid pharmaceutical composition containing benzofuran derivative
|
|
CN102372760A
|
|
Synthesis method of progesterone receptor regulating agent ulipristal
|
|
CN102344392A
|
|
Method for refining histone deacetylase (HDAC) inhibitor vorinostat
|
|
CN102241722A
|
|
Method for purifying ulipristal serving as synthetic progesterone receptor regulator
|
|
CN101993469A
|
|
Method for preparing medicinal dienogest
|
|
CN101993468A
|
|
Synthesis method for improving dienogest
|
|
CN101536989A
|
|
Metformin hydrochloride intragastric floating sustained-release tablet and preparation method thereof
|
|
CN101469012A
|
|
Method for synthesizing 2-amino-6-methoxy-9-(beta-D-aralino)-9H-purine
|
|
CN101434571A
|
|
Cycloalkano [1,2-b] indole sulfonic acid amide, and method for synthesizing isomer or salt thereof
|
|
CN101050216A
|
|
Method for synthesizing medication Entecavir of anti hepatitis B
|
